[ is distinct conversations ]. And live here this morning on c spann span 3, a discussion about transparency and oversight at the food and Drug Administration. Well be hearing from dr. Scott gottlieb starting off the conference. Introductions under way. Efforts to pass and implement the food safety modernization act, focus on medical devices, especially the potential of using the unique device identifier to improve monitoring devices throughout the product lifecycle. We have successfully worked on products 10 to courage innovation particularly around antibiotics and 10 to sure appropriate use of them. We focused on drug safety and transparency in the supply chain and especially on the safety of compounded drugs. Among other things, pew submitted transparency to the task force back in 2010 if the. They touch on some of the topics well be discussing today. Reading the background papers for todays meet regular mind med of a meeting we convened in a room directly above of us here a few yea
Process to approve new drugs. This is 35 minutes. Thanks a lot. Thanks for the opportunity to be here today. We had a dialogue over many years, and i appreciate the relationship we had talking about policy issues. I wrote a subsequent article saying whats taking you so long, josh. So ive been waiting for him to return the favor, and i just got a copy of it. So i appreciate it very much. Thanks for the opportunity to be here today. Thanks john hopkins for hoestin this, and pew for providing space. Transparency can be a powerful tool for innovation. New platforms for visualizing large complex data sets present important new opportunities for the research and Development Community for regulators and for clinicians. It allows people to harness data to advance the safe and effective and Efficient Development for medical needs and to communicate information supporting regulatory Decision Making in ways that engender Greater Public confidence in those decisions. The fdas goal is to advance tr
I wrote a subsequent article saying whats taking you so long, josh. So ive been waiting for him to return the favor, and i just got a copy of it. So i appreciate it very much. Thanks for the opportunity to be here today. Thanks john hopkins for hoestin this, and pew for providing space. Transparency can be a powerful tool for innovation. New platforms for visualizing large complex data sets present important new opportunities for the research and Development Community for regulators and for clinicians. It allows people to harness data to advance the safe and effective and Efficient Development for medical needs and to communicate information supporting regulatory Decision Making in ways that engender Greater Public confidence in those decisions. The fdas goal is to advance transparency without reducing incentives to innovate. This can be accomplished by meeting our statutory responsibility for protecting confidential, commercial information, trade secrets and private data while dissemi
To lawmakers about Mental Health care and Suicide Prevention programs for veterans and their families. The witnesses testify on why some are not receiving the necessary treatment and how a new law passed last year is trying to address the issue. This hearing is two and a half hours. [inaudible conversations] committee come to order. Good morning, everybody. Thank you for being with the committee for todays oversight hearing entitled combating the crisis evaluating efforts to prevent veteran suicide. As the hearing title suggests, we are here this morning to discuss the ongoing veteran suicide crisis that, according to the latest Data Available from the department of Veterans Affairs, finds 22 veterans a day dying at their own hands. Im disappointed that the v. A. Was not able to release updated veteran suicide statistics at this time for this hearing. I understand that the center for Disease Control finally provided National Data to v. A. In the middle of march. Considering the critica
Lifetime job so that we wouldnt feel pressure to do a decision based on Public Opinion from fear that somehow we will be driven from our work. And so were not thinking about Public Opinion in terms of reaching the answer that we believe the law compels. Every year, if you read our most sensitive decisions, you will see us recognizing the impact those decisions might have on people. In every sensitive opinion the court is very aware when one of its decisions is going to be particularly difficult for some people in the society. Its recognized in our writing. But we do take pride on the fact that we are voting according to what we think the constitution or the laws require. That means that we can be aware of what the effect will be. We can even acknowledge it. But thats a different thing from letting it determine the outcome of a decision. [ applause ] now, would the students please not leave . Im coming down now. I would like to take a picture with the students who are here because they